Literature DB >> 34643714

Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders.

Thomas Robert1,2, Guillaume Lano1,3, Matthieu Giot1, Toscane Fourié4, Xavier de Lamballeri4, Océane Jehel1, Dammar Bouchouareb1, Philippe Brunet1,3, Laetitia Ninove4, Stéphane Burtey1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34643714     DOI： 10.1093/ndt/gfab299

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Humoral and Cellular Immune Response After a 3-Dose Heterologous SARS-CoV-2 Vaccination Using the mRNA-BNT162b2 and Viral Vector Ad26COVS1 Vaccine in Hemodialysis Patients.

Authors:  Tamara Davidovic; Judith Schimpf; Armin Abbassi-Nik; Richard Stockinger; Hannelore Sprenger-Mähr; Karl Lhotta; Emanuel Zitt
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

2.  Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients.

Authors:  José Jesús Broseta; Diana Rodríguez-Espinosa; Elena Cuadrado; Néstor Rodríguez; José Luis Bedini; Francisco Maduell
Journal:  Vaccines (Basel)       Date:  2022-03-27

3.  Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France.

Authors:  Jean-François Verdier; Sonia Boyer; Florence Chalmin; Ahmed Jeribi; Caroline Egasse; Marie France Maggi; Philippe Auvray; Tarik Yalaoui
Journal:  BMC Nephrol       Date:  2022-05-18       Impact factor: 2.585

4.  Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.

Authors:  Jessica Bassi; Olivier Giannini; Chiara Silacci-Fregni; Laura Pertusini; Paolo Hitz; Tatiana Terrot; Yves Franzosi; Francesco Muoio; Christian Saliba; Marcel Meury; Exequiel A Dellota; Josh R Dillen; Patrick Hernandez; Nadine Czudnochowski; Elisabetta Cameroni; Nicola Beria; Mariangela Ventresca; Alberto Badellino; Soraya Lavorato-Hadjeres; Elisabetta Lecchi; Tecla Bonora; Matteo Mattiolo; Guido Trinci; Daniela Garzoni; Giuseppe Bonforte; Valentina Forni-Ogna; Davide Giunzioni; Lorenzo Berwert; Ravindra K Gupta; Paolo Ferrari; Alessandro Ceschi; Pietro Cippà; Davide Corti; Antonio Lanzavecchia; Luca Piccoli
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

5.  Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients.

Authors:  Pierre Housset; Sabah Kubab; Agathe Pardon; Nathalie Vittoz; Dogan-Firat Bozman; Latifa Hanafi; Valérie Caudwell; Anne-Laure Faucon
Journal:  J Nephrol       Date:  2022-02-22       Impact factor: 4.393

6.  SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients.

Authors:  Xiaoling Wang; Maggie Han; Lemuel Rivera Fuentes; Ohnmar Thwin; Nadja Grobe; Kevin Wang; Yuedong Wang; Peter Kotanko
Journal:  Front Nephrol       Date:  2022-07-22

Review 7.  A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time?

Authors:  Ayman El-Menyar; Naushad Ahmad Khan; Ahammed Mekkodathil; Sandro Rizoli; Rafael Consunji; Eman Elmenyar; Sagar Galwankar; Hassan Al-Thani
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.